Production (Stage)
CureVac N.V.
CVAC
$5.54
-$0.03-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.81M | 162.71M | 167.81M | -78.08M | -76.59M |
| Total Depreciation and Amortization | 4.82M | 4.22M | 4.35M | 5.52M | 5.28M |
| Total Amortization of Deferred Charges | -- | 477.00K | 492.00K | -- | -- |
| Total Other Non-Cash Items | 230.50K | 41.52M | 42.83M | -9.29M | 16.87M |
| Change in Net Operating Assets | 6.22M | -55.69M | -57.44M | -14.06M | -50.38M |
| Cash from Operations | -43.54M | 153.24M | 158.05M | -95.92M | -104.82M |
| Capital Expenditure | -509.30K | -3.11M | -3.20M | -3.67M | -5.51M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.40K | -21.90K | -22.50K | -4.39M | -15.20K |
| Cash from Investing | -537.70K | -3.13M | -3.23M | -8.06M | -5.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.31M | -1.32M | -1.32M | -1.26M | -1.22M |
| Issuance of Common Stock | -- | -- | -- | 43.00K | 95.00K |
| Repurchase of Common Stock | -- | -69.00K | -69.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -500.00 | -500.00 | 1.00K | -- |
| Cash from Financing | -1.38M | -1.48M | -1.52M | -1.31M | -1.22M |
| Foreign Exchange rate Adjustments | -231.50K | 190.80K | 196.80K | 192.70K | 505.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.69M | 148.83M | 153.49M | -105.09M | -111.06M |